Immunoprecise Current Liabilities vs Property Plant and Equipment Net Analysis

IPA
 Stock
  

USD 4.04  0.05  1.22%   

Immunoprecise Antibodies financial indicator trend analysis is infinitely more than just investigating Immunoprecise Antibodies recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Immunoprecise Antibodies is a good investment. Please check the relationship between Immunoprecise Antibodies Current Liabilities and its Property Plant and Equipment Net accounts. Please see Risk vs Return Analysis.

Current Liabilities vs Property Plant and Equipment Net

Current Liabilities vs Property Plant and Equipment Net Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Immunoprecise Antibodies Current Liabilities account and Property Plant and Equipment Net. At this time, the significance of the direction appears to have weak relationship.
The correlation between Immunoprecise Antibodies' Current Liabilities and Property Plant and Equipment Net is 0.37. Overlapping area represents the amount of variation of Current Liabilities that can explain the historical movement of Property Plant and Equipment Net in the same time period over historical financial statements of Immunoprecise Antibodies, assuming nothing else is changed. The correlation between historical values of Immunoprecise Antibodies' Current Liabilities and Property Plant and Equipment Net is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Liabilities of Immunoprecise Antibodies are associated (or correlated) with its Property Plant and Equipment Net. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Property Plant and Equipment Net has no effect on the direction of Current Liabilities i.e., Immunoprecise Antibodies' Current Liabilities and Property Plant and Equipment Net go up and down completely randomly.

Correlation Coefficient

0.37
Relationship DirectionPositive 
Relationship StrengthVery Weak

Current Liabilities

The current portion of Total Liabilities; reported if the company operates a classified balance sheet that segments current and non-current liabilities.

Property Plant and Equipment Net

A component of Total Assets representing the amount after accumulated depreciation; depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Includes Operating Right of Use Assets.
Most indicators from Immunoprecise Antibodies fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Immunoprecise Antibodies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Please see Risk vs Return Analysis.Immunoprecise Antibodies Selling General and Administrative Expense is projected to increase significantly based on the last few years of reporting. The past year's Selling General and Administrative Expense was at 8.53 Million. The current year Issuance Purchase of Equity Shares is expected to grow to about 4 M, whereas Net Cash Flow Business Acquisitions and Disposals is forecasted to decline to (3.8 M).
 2019 2020 2021 2022 (projected)
Interest Expense537 K517 K334 K365.43 K
Gross Profit8.03 M11.54 M10.98 M10.97 M

Immunoprecise Antibodies fundamental ratios Correlations

0.910.870.9-0.25-0.730.320.51.00.841.00.890.890.850.620.920.990.820.70.830.87
0.910.591.0-0.08-0.950.60.510.940.540.880.740.740.570.270.690.860.890.750.980.62
0.870.590.56-0.39-0.31-0.090.370.841.00.910.860.860.980.90.980.920.550.470.440.97
0.91.00.56-0.11-0.960.590.470.920.520.860.70.70.530.220.660.840.870.720.990.59
-0.25-0.08-0.39-0.11-0.050.710.68-0.25-0.44-0.250.080.08-0.22-0.21-0.21-0.240.320.510.01-0.41
-0.73-0.95-0.31-0.96-0.05-0.74-0.46-0.77-0.25-0.68-0.53-0.53-0.290.04-0.43-0.65-0.84-0.7-0.99-0.35
0.320.6-0.090.590.71-0.740.730.35-0.160.270.380.380.0-0.230.110.260.770.790.69-0.09
0.50.510.370.470.68-0.460.730.490.320.520.780.780.530.430.550.530.850.950.510.38
1.00.940.840.92-0.25-0.770.350.490.80.990.870.870.810.570.890.980.830.70.860.84
0.840.541.00.52-0.44-0.25-0.160.320.80.880.820.820.970.90.960.890.480.410.390.97
1.00.880.910.86-0.25-0.680.270.520.990.880.920.920.890.690.951.00.810.70.780.91
0.890.740.860.70.08-0.530.380.780.870.820.921.00.920.790.950.930.860.850.650.86
0.890.740.860.70.08-0.530.380.780.870.820.921.00.920.790.950.930.860.850.650.86
0.850.570.980.53-0.22-0.290.00.530.810.970.890.920.920.940.990.910.620.590.430.96
0.620.270.90.22-0.210.04-0.230.430.570.90.690.790.790.940.870.710.370.40.120.89
0.920.690.980.66-0.21-0.430.110.550.890.960.950.950.950.990.870.960.70.650.560.96
0.990.860.920.84-0.24-0.650.260.530.980.891.00.930.930.910.710.960.80.70.760.91
0.820.890.550.870.32-0.840.770.850.830.480.810.860.860.620.370.70.80.970.880.57
0.70.750.470.720.51-0.70.790.950.70.410.70.850.850.590.40.650.70.970.750.49
0.830.980.440.990.01-0.990.690.510.860.390.780.650.650.430.120.560.760.880.750.49
0.870.620.970.59-0.41-0.35-0.090.380.840.970.910.860.860.960.890.960.910.570.490.49
Click cells to compare fundamentals

Immunoprecise Antibodies Account Relationship Matchups

Be your own money manager

Our tools can tell you how much better you can do entering a position in Immunoprecise Antibodies without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Premium Stories Now

   

Premium Stories

Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Immunoprecise Antibodies using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Risk vs Return Analysis. Note that the Immunoprecise Antibodies information on this page should be used as a complementary analysis to other Immunoprecise Antibodies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for Immunoprecise Stock analysis

When running Immunoprecise Antibodies price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Is Immunoprecise Antibodies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunoprecise Antibodies. If investors know Immunoprecise will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunoprecise Antibodies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
101.1 M
Quarterly Revenue Growth YOY
0.074
Return On Assets
-0.13
Return On Equity
-0.25
The market value of Immunoprecise Antibodies is measured differently than its book value, which is the value of Immunoprecise that is recorded on the company's balance sheet. Investors also form their own opinion of Immunoprecise Antibodies' value that differs from its market value or its book value, called intrinsic value, which is Immunoprecise Antibodies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunoprecise Antibodies' market value can be influenced by many factors that don't directly affect Immunoprecise Antibodies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunoprecise Antibodies' value and its price as these two are different measures arrived at by different means. Investors typically determine Immunoprecise Antibodies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunoprecise Antibodies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.